o2h Technology appoints serial entrepreneur Fiona Nielsen as Chief Operations Officer

Cambridge, UK, July 1 2021: o2h technology, the software services business unit of the o2h Group, today announced it has appointed Fiona Nielsen as Chief Operations Officer, in line with recent business growth and increasing customer demand.

Fiona Nielsen brings 20 years of experience in the technology and life science industry. With a background in computer science combined with her degree in Bioinformatics Fiona arrived in Cambridge, UK, to work for deep-tech life science company Illumina before emerging as an entrepreneur in genomics and life science. In her latest venture Repositive Fiona built a data organisation and inventory management platform for genomics and clinical data, showcasing available cancer models within their global network of preclinical contract research organisations.

During her tenure at Repositive Fiona negotiated contracts and closed sales and partner agreements across 25+ international biopharmas and CROs, including AstraZeneca, Boehringer Ingelheim.

Prashant Shah, Executive Chairman of the o2h Group, said: “We are pleased to announce we have brought Fiona on board o2h Technology to lead the expansion of our business especially within life science and green tech clients and support the growing ecosystem of entrepreneurs and ideas emerging around our exciting new o2h co-working space opening at the Mill in Hauxton.”

“I am truly excited about leading the growth and further specialisation of the o2h Technology team into life sciences and green tech. The team at o2h is fantastic and I am proud to be continuing the inclusive and innovative culture of o2h Group.” said Fiona Nielsen, Chief Operations Officer, o2h technology.

About o2h technology

o2h technology is a division of the o2h group which employs 450+ people based in Cambridge, UK and Ahmedabad and seeds new ideas in life-science, technology and green innovation. o2h technology was officially founded in 2017 to support cross fertilisation of ideas being generated from within the life-science and investment divisions.

For more information, please see - www.o2htechnology.com

About o2h group

o2h group seeds new ideas in science, technology and social enterprise. We work across boundaries and take a collaborative and shared approach to innovation, and therefore we co-invest, co-create and co-execute to bring these ideas to life. o2h group is organised into 6 symbiotic verticals; o2h ventures, o2h discovery, o2h therapeutics, o2h technology, o2h co-work, and o2h community.

o2h group has visualised a home in the form of two iconic state-of-the-art research parks bridging India and Europe, and firmly taking a place alongside some of the most exciting innovation cultures and communities from around the world. The first of these research parks is being built on the recently acquired 2.76 acre heritage Hauxton Mill site in the UK, with plans to develop it into The Mill SciTech Park to create one of the region’s most exciting community of entrepreneurs in life-science, technology and social enterprise.

For more information, please see – www.o2h.com

Notes to Editors

Ajit Singh Guller
Marketing Manager, o2h group
ajit@o2h.com


Attached Media


About o2h Ventures Limited

o2h Ventures Limited has launched the o2h Therapeutics and AI fund which is the first S/EIS fund in the UK solely focused on early stage biotech therapeutics and related AI opportunities. The geographic scope shall be UK wide including Oxford and London but will target the growing Cambridge biotech cluster. The Fund is structured to be S/EIS compliant providing tax breaks for UK taxpayers. The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years. o2h operate from their proprietary 2.7 acre The Mill SciTech Park where they are developing a unique model for incubating small life science companies. For further information: www.o2h.com/ventures


Press Contacts